Ferring GmbH (manufacturer of the finished product, responsible for primary packaging, quality control and batch release)

Ukraine

All drugs from this manufacturer

  • FIRMAGON

    The drug is intended for the treatment of adult men with advanced hormone-sensitive prostate cancer.

    Dosage form: powder for injection solution

    Active substance Dosage
    degarelix 80 mg

    ATC: L02BX02

  • The drug is intended for the treatment of adult men with advanced hormone-sensitive prostate cancer.

    Dosage form: powder for injection solution

    Active substance Dosage
    degarelix 120 mg

    ATC: L02BX02

  • The drug is used for emergency assistance in bleeding from esophageal varices, as well as for adjuvant therapy in combination with endoscopic methods and to reduce the risk of rebleeding.

    Dosage form: powder for injection solution

    Active substance Dosage
    terlipressin 1 mg

    ATC: H01BA04